Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly could net $1.5B-plus from Cymbalta extension
Lilly could net $1.5B-plus from Cymbalta extension
Lilly could net $1.5B-plus from Cymbalta extension
Submitted by
admin
on July 11, 2012 - 12:08pm
Source:
Fierce Pharma
News Tags:
Eli Lilly
Cymbalta
antidepressants
Headline:
Lilly could net $1.5B-plus from Cymbalta extension
Do Not Allow Advertisers to Use My Personal information
